A cross-sectional study of quality of life among Brazilian adults with type 1 diabetes treated with insulin glargine: findings and implications

Paulo H.R.F. Almeida, Brian Godman, Vania dos Santos Nunes-Nogueira, Livia L. P. de Lemos, Francisco de Assis Acúrcio, Augusto A. Guerra Júnior, Vânia E. de Araújo, Alessandra M. Almeida, Juliana Alvares-Teodoro

Research output: Contribution to journalArticlepeer-review

6 Downloads (Pure)

Abstract

We conducted a cross-sectional study with 401 patients of type 1 diabetes mellitus treated with insulin glargine in Minas Gerais, Brazil. Health-related quality of life (HRQoL) was assessed using EQ-5D-3L and the Diabetes Quality of Life Measure. Our findings showed that a worse HRQoL was associated with a low level of education, self-perceived health reported as poor/very poor, being bedridden and not physically exercised, had seen a doctor more than four times in the past year before the interview, and had reported comorbidities and episodes of hypoglycemia.
Original languageEnglish
Number of pages20
JournalClinical Diabetes
Publication statusAccepted/In press - 6 Dec 2021

Keywords

  • Brazil
  • type 1 diabetes
  • insulin glargine
  • health-related quality of life

Fingerprint

Dive into the research topics of 'A cross-sectional study of quality of life among Brazilian adults with type 1 diabetes treated with insulin glargine: findings and implications'. Together they form a unique fingerprint.

Cite this